Trajan Group Holdings Limited (ASX:TRJ)

Market Cap	51.88M -57.4%
Revenue (ttm)	169.52M +6.2%
Net Income	-1.38M
EPS	-0.01
Shares Out	152.59M
PE Ratio	n/a
Forward PE	9.21
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,216
Average Volume	60,057
Open	0.3500
Previous Close	0.3400
Day's Range	0.3500 - 0.3500
52-Week Range	0.3300 - 0.9700
Beta	0.57
RSI	40.60
Earnings Date	May 27, 2026

About Trajan Group Holdings

Trajan Group Holdings Limited develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India. The company offers analytical products, including syringes, GC columns and septa, inlet liners, rings, and tubing products; and sampling products, comprising septa, caps, liners, well plates and sealing mats, crimping tools, and micro sampling tools, as well as automation systems and consumables. It also provides pathology produ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Employees: 630
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: TRJ

Financial Performance

In fiscal year 2025, Trajan Group Holdings's revenue was 166.46 million, an increase of 7.38% compared to the previous year's 155.02 million. Losses were -4.46 million, -82.39% less than in 2024.